CLDX
Price
$24.48
Change
+$0.25 (+1.03%)
Updated
Jan 23, 04:31 PM (EDT)
Capitalization
1.61B
39 days until earnings call
ZLDPF
Price
$100.86
Change
+$0.30 (+0.30%)
Updated
Jan 22 closing price
Capitalization
7.21B
Ad is loading...

CLDX vs ZLDPF

Header iconCLDX vs ZLDPF Comparison
Open Charts CLDX vs ZLDPFBanner chart's image
Celldex Therapeutics
Price$24.48
Change+$0.25 (+1.03%)
Volume$734
Capitalization1.61B
Zealand Pharma A/S
Price$100.86
Change+$0.30 (+0.30%)
Volume$224
Capitalization7.21B
CLDX vs ZLDPF Comparison Chart
Loading...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLDPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDX vs. ZLDPF commentary
Jan 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDX is a Hold and ZLDPF is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 24, 2025
Stock price -- (CLDX: $24.24 vs. ZLDPF: $100.86)
Brand notoriety: CLDX and ZLDPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDX: 50% vs. ZLDPF: 19%
Market capitalization -- CLDX: $1.61B vs. ZLDPF: $7.21B
CLDX [@Biotechnology] is valued at $1.61B. ZLDPF’s [@Biotechnology] market capitalization is $7.21B. The market cap for tickers in the [@Biotechnology] industry ranges from $355.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDX’s FA Score shows that 0 FA rating(s) are green whileZLDPF’s FA Score has 2 green FA rating(s).

  • CLDX’s FA Score: 0 green, 5 red.
  • ZLDPF’s FA Score: 2 green, 3 red.
According to our system of comparison, ZLDPF is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDX’s TA Score shows that 4 TA indicator(s) are bullish while ZLDPF’s TA Score has 2 bullish TA indicator(s).

  • CLDX’s TA Score: 4 bullish, 3 bearish.
  • ZLDPF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, both CLDX and ZLDPF are a good buy in the short-term.

Price Growth

CLDX (@Biotechnology) experienced а +7.16% price change this week, while ZLDPF (@Biotechnology) price change was +5.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.08%. For the same industry, the average monthly price growth was +3.31%, and the average quarterly price growth was -1.03%.

Reported Earning Dates

CLDX is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+4.08% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZLDPF($7.21B) has a higher market cap than CLDX($1.61B). ZLDPF YTD gains are higher at: -1.465 vs. CLDX (-4.076). CLDX has higher annual earnings (EBITDA): -171.06M vs. ZLDPF (-1B). ZLDPF has more cash in the bank: 8.47B vs. CLDX (756M). CLDX has less debt than ZLDPF: CLDX (3.09M) vs ZLDPF (389M). ZLDPF has higher revenues than CLDX: ZLDPF (76.9M) vs CLDX (9.98M).
CLDXZLDPFCLDX / ZLDPF
Capitalization1.61B7.21B22%
EBITDA-171.06M-1B17%
Gain YTD-4.076-1.465278%
P/E RatioN/AN/A-
Revenue9.98M76.9M13%
Total Cash756M8.47B9%
Total Debt3.09M389M1%
FUNDAMENTALS RATINGS
CLDX vs ZLDPF: Fundamental Ratings
CLDX
ZLDPF
OUTLOOK RATING
1..100
421
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
80
Overvalued
PROFIT vs RISK RATING
1..100
4822
SMR RATING
1..100
9695
PRICE GROWTH RATING
1..100
8558
P/E GROWTH RATING
1..100
1006
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLDX's Valuation (56) in the Biotechnology industry is in the same range as ZLDPF (80) in the null industry. This means that CLDX’s stock grew similarly to ZLDPF’s over the last 12 months.

ZLDPF's Profit vs Risk Rating (22) in the null industry is in the same range as CLDX (48) in the Biotechnology industry. This means that ZLDPF’s stock grew similarly to CLDX’s over the last 12 months.

ZLDPF's SMR Rating (95) in the null industry is in the same range as CLDX (96) in the Biotechnology industry. This means that ZLDPF’s stock grew similarly to CLDX’s over the last 12 months.

ZLDPF's Price Growth Rating (58) in the null industry is in the same range as CLDX (85) in the Biotechnology industry. This means that ZLDPF’s stock grew similarly to CLDX’s over the last 12 months.

ZLDPF's P/E Growth Rating (6) in the null industry is significantly better than the same rating for CLDX (100) in the Biotechnology industry. This means that ZLDPF’s stock grew significantly faster than CLDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLDXZLDPF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 16 days ago
75%
Bullish Trend 16 days ago
64%
Momentum
ODDS (%)
Bullish Trend 16 days ago
83%
N/A
MACD
ODDS (%)
Bullish Trend 16 days ago
85%
N/A
TrendWeek
ODDS (%)
Bullish Trend 16 days ago
83%
Bearish Trend 16 days ago
45%
TrendMonth
ODDS (%)
Bullish Trend 16 days ago
81%
Bearish Trend 16 days ago
40%
Advances
ODDS (%)
Bullish Trend 21 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 25 days ago
79%
Bearish Trend 21 days ago
53%
BollingerBands
ODDS (%)
Bearish Trend 16 days ago
90%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 16 days ago
71%
View a ticker or compare two or three
Ad is loading...
CLDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLDPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEGZX22.800.06
+0.26%
PGIM Jennison Mid-Cap Growth Z
NARCX53.83-0.02
-0.04%
Voya Multi-Manager International Sm Cp C
SQBIX14.18-0.08
-0.56%
X-Square Balanced Fund, LLC Instl
FFGIX18.75-0.13
-0.69%
Fidelity Advisor Global Commodity Stk I
VEVRX47.50-0.40
-0.84%
Victory Sycamore Established Value R6

ZLDPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZLDPF has been loosely correlated with KRYS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ZLDPF jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZLDPF
1D Price
Change %
ZLDPF100%
+0.30%
KRYS - ZLDPF
46%
Loosely correlated
+1.26%
CLDX - ZLDPF
30%
Poorly correlated
-1.50%
NERV - ZLDPF
22%
Poorly correlated
-3.43%
SNDX - ZLDPF
22%
Poorly correlated
+2.41%
MIST - ZLDPF
22%
Poorly correlated
-7.01%
More